These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 15645238)
21. Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein. Keogh JP; Kunta JR Eur J Pharm Sci; 2006 Apr; 27(5):543-54. PubMed ID: 16406207 [TBL] [Abstract][Full Text] [Related]
22. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats. Yigitaslan S; Erol K; Cengelli C Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555 [TBL] [Abstract][Full Text] [Related]
23. Plant polyphenols and multidrug resistance: effects of dietary flavonoids on drug transporters in Caco-2 and MDCKII-MDR1 cell transport models. Rodriguez-Proteau R; Mata JE; Miranda CL; Fan Y; Brown JJ; Buhler DR Xenobiotica; 2006 Jan; 36(1):41-58. PubMed ID: 16507512 [TBL] [Abstract][Full Text] [Related]
24. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats. Yang CY; Chao PD; Hou YC; Tsai SY; Wen KC; Hsiu SL Food Chem Toxicol; 2006 Sep; 44(9):1572-8. PubMed ID: 16762474 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of intestinal P-glycoprotein and effects on etoposide absorption. Leu BL; Huang JD Cancer Chemother Pharmacol; 1995; 35(5):432-6. PubMed ID: 7850926 [TBL] [Abstract][Full Text] [Related]
26. Polysorbate 20 increases oral absorption of digoxin in wild-type Sprague Dawley rats, but not in mdr1a(-/-) Sprague Dawley rats. Nielsen CU; Abdulhussein AA; Colak D; Holm R Int J Pharm; 2016 Nov; 513(1-2):78-87. PubMed ID: 27601334 [TBL] [Abstract][Full Text] [Related]
27. Effect of P-glycoprotein on the rat intestinal permeability and metabolism of the BDDCS class 1 drug verapamil. Estudante M; Maya M; Morais JG; Soveral G; Benet LZ Mol Pharm; 2013 Nov; 10(11):4038-45. PubMed ID: 24044638 [TBL] [Abstract][Full Text] [Related]
28. Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug. Toyobuku H; Tamai I; Ueno K; Tsuji A J Pharm Sci; 2003 Nov; 92(11):2249-59. PubMed ID: 14603510 [TBL] [Abstract][Full Text] [Related]
29. Does inhibition of P-glycoprotein lead to drug-drug interactions? Balayssac D; Authier N; Cayre A; Coudore F Toxicol Lett; 2005 Apr; 156(3):319-29. PubMed ID: 15763631 [TBL] [Abstract][Full Text] [Related]
30. P-glycoprotein-mediated intestinal and biliary digoxin transport in humans. Drescher S; Glaeser H; Mürdter T; Hitzl M; Eichelbaum M; Fromm MF Clin Pharmacol Ther; 2003 Mar; 73(3):223-31. PubMed ID: 12621387 [TBL] [Abstract][Full Text] [Related]
31. Comparison of P-glycoprotein-mediated drug-digoxin interactions in Caco-2 with human and rodent intestine: relevance to in vivo prediction. Collett A; Tanianis-Hughes J; Carlson GL; Harwood MD; Warhurst G Eur J Pharm Sci; 2005 Dec; 26(5):386-93. PubMed ID: 16153812 [TBL] [Abstract][Full Text] [Related]
32. Elevated blood concentrations of calcineurin inhibitors during diarrheal episode in pediatric liver transplant recipients: involvement of the suppression of intestinal cytochrome P450 3A and P-glycoprotein. Maezono S; Sugimoto K; Sakamoto K; Ohmori M; Hishikawa S; Mizuta K; Kawarasaki H; Watanabe Y; Fujimura A Pediatr Transplant; 2005 Jun; 9(3):315-23. PubMed ID: 15910387 [TBL] [Abstract][Full Text] [Related]
33. The complexity of intestinal absorption and exsorption of digoxin in rats. Yao HM; Chiou WL Int J Pharm; 2006 Sep; 322(1-2):79-86. PubMed ID: 16781832 [TBL] [Abstract][Full Text] [Related]
34. Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin. Ghanem CI; Gómez PC; Arana MC; Perassolo M; Delli Carpini G; Luquita MG; Veggi LM; Catania VA; Bengochea LA; Mottino AD J Pharmacol Exp Ther; 2006 Sep; 318(3):1146-52. PubMed ID: 16740618 [TBL] [Abstract][Full Text] [Related]
35. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Cornaire G; Woodley J; Hermann P; Cloarec A; Arellano C; Houin G Int J Pharm; 2004 Jun; 278(1):119-31. PubMed ID: 15158955 [TBL] [Abstract][Full Text] [Related]
37. Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance. Le Bot MA; Kernaleguen D; Robert J; Berlion M; Riché C Cancer Chemother Pharmacol; 1994; 35(1):53-8. PubMed ID: 7987977 [TBL] [Abstract][Full Text] [Related]
38. Intestinal absorption of digoxin and interaction with nimodipine in rats. Kilic FS; Batu O; Sirmagul B; Yildirim E; Erol K Pol J Pharmacol; 2004; 56(1):137-41. PubMed ID: 15047988 [TBL] [Abstract][Full Text] [Related]
39. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability. Varma MV; Panchagnula R J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467 [TBL] [Abstract][Full Text] [Related]
40. The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Hayeshi R; Masimirembwa C; Mukanganyama S; Ungell AL Eur J Pharm Sci; 2006 Sep; 29(1):70-81. PubMed ID: 16846720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]